5-Methyl-12-oxo-N-(3,4,5-trimethoxyphenyl)-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide

Catalog No. :
ACJJYY280
CAS No. :
1775442-93-7
Molecular Formula :
C24H29N3O5
Molecular Weight :
439.51

IUPAC Name:5-methyl-12-oxo-N-(3,4,5-trimethoxyphenyl)-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide

5-Methyl-12-oxo-N-(3,4,5-trimethoxyphenyl)-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methyl-12-oxo-N-(3,4,5-trimethoxyphenyl)-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide
IUPAC Name5-methyl-12-oxo-N-(3,4,5-trimethoxyphenyl)-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide
Molecular FormulaC24H29N3O5
Molecular Weight439.51
SMILESO=C(C1=CC(N(C)C2N3CCCCC2)=C(C=C1)C3=O)NC4=CC(OC)=C(OC)C(OC)=C4
InChI KeyHITUXCHLXNNFOF-UHFFFAOYSA-N
Synonym5-methyl-12-oxo-N-(3,4,5-trimethoxyphenyl)-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide;Azepino[2,1-b]quinazoline-3-carboxamide, 5,5a,6,7,8,9,10,12-octahydro-5-methyl-12-oxo-N-(3,4,5-trimethoxyphenyl)-
CAS No.1775442-93-7

Synthetic Route by SureRoute

1. ACJJYY280 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJJYY280 route product structure diagram
    ACJJYY2801775442-93-7
Inquiry

2. ACJJYY280 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJJYY280 route product structure diagram
    ACJJYY2801775442-93-7
Inquiry

Comments (0)